mouse anti-serca2 iid8 (Millipore)
Millipore is a verified supplier 
90
Structured Review
Millipore
mouse anti-serca2 iid8
Mouse Anti Serca2 Iid8, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-serca2+iid8/anti+serca2/pm37561594-145-0-7
Average 90 stars, based on 1 article reviews
Mouse Anti Serca2 Iid8, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-serca2+iid8/anti+serca2/pm37561594-145-0-7
Average 90 stars, based on 1 article reviews
mouse anti-serca2 iid8 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Expressing:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Reverse Transcription Polymerase Chain Reaction:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Western Blot:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Transfection:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Binding Assay:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Luciferase:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Reporter Assay:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Construct:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Sequencing:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Inhibition:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Activity Assay:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Negative Control:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Plasmid Preparation:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Real-time Polymerase Chain Reaction:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), Fluorescence:Article Title: Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. Article Snippet: Article Title: HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility Article Snippet: Antibodies used in this study were purchased from the following sources: rabbit anti-mouse HIF-1α (NB100-479, Novus Biologicals), |
